India 2017: Specialty drugs to remain focus of pharma M&As

India 2017: Specialty drugs to remain focus of pharma M&As

Photo: Pradeep Gaur/Mint

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter